Stay updated on Secukinumab Long-term Efficacy in PsA Clinical Trial

Sign up to get notified when there's something new on the Secukinumab Long-term Efficacy in PsA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Secukinumab Long-term Efficacy in PsA Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record presents details of a completed three-year secukinumab extension study for psoriatic arthritis, including its design, eligibility, treatment arms, outcome measures, and study locations. It also includes study dates, publications, and protocol documents.
    Difference
    99%
    Check dated 2026-11-11T17:20:46.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T15:39:27.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-21T20:23:19.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-14T20:09:51.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1. The page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T20:41:35.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the previous study record content with an error screen. This indicates the page is currently inaccessible, likely due to access restrictions, while the rest of the ClinicalTrials.gov site remains available.
    Difference
    19%
    Check dated 2026-09-23T20:39:34.000Z thumbnail image

Stay in the know with updates to Secukinumab Long-term Efficacy in PsA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Secukinumab Long-term Efficacy in PsA Clinical Trial page.